30Oct
[Video] I Wish I Knew What I Know Now: Conversations with AGG on FDA Issues - Key Due Diligence Issues to Consider When Acquiring or Investing in Life Sciences Companies or Products
AGG is pleased to present the second episode in a podcast series titled, “I Wish I Know What I Know Now: Conversations with AGG on FDA Issues,” covering key due diligence issues to consider when acquiring or investing in life science companies or products. In this episode, AGG partner Alan G. Minsk and Brian A. Teras provides an overview of the diligence process, potential red flags, common mistakes, and other factors to consider during the due diligence process. Each month, we'll release a...
By:
Arnall Golden Gregory LLP
Related
Job descriptions are a crucial part of recruitment and hiring, and of performing an Equal Pay Act An...
Read More >
In preparation for a webinar I gave this week with my colleague Chris Engler, I took a deeper dive ...
Read More >
Under the federal Uniformed Services Employment and Reemployment Rights Act (USERRA), employers are ...
Read More >
The Securities and Exchange Commission has adopted amendments to the disclosure requirements for bus...
Read More >
Can contractors “shop” bids after obtaining and using them to obtain contract awards? Generally s...
Read More >
In Revenue Ruling 2019-19, the IRS answered three basic questions about the consequences of an indiv...
Read More >